Skip to content

Clinical trials

Phase 2/3 Genetic Diseases, Inborn trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Phase: Phase 2/3 Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20091
20111
20151
20181
20212
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Withdrawn2
Active, not recruiting1
Enrolling by invitation1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AO GENERIUM2
BioMarin Pharmaceutical1
Children's Hospital of Fudan University1
Novartis Pharmaceuticals1
Pharming Technologies B.V.1
QED Therapeutics, a BridgeBio company1
Radboud University Medical Center1
University of Washington, the Collaborative Health Studies Coordinating Center1
Vertex Pharmaceuticals Incorporated1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn10
Bone Diseases2
Digestive System Diseases2
Musculoskeletal Diseases2
Osteochondrodysplasias2
Achondroplasia1
Adenoma1
Adenomatous Polyposis Coli1
Adenomatous Polyps1
Angioedema1

Trials

Showing 76 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.